How Much Does Ozempic Cost in 2026? The Real Numbers, Not the Headlines

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 12 sources cited · As of May 2026 — confirm current pricing directly with the pharmacy or manufacturer.

Key Takeaways

• Cash retail for a one-month Ozempic pen averages around $998 in May 2026, with real pharmacy-to-pharmacy quotes ranging from roughly $920 to $1,080
• Insurance copays for a covered type 2 diabetes prescription commonly land between $25 and $80 per month, but plans with high deductibles can charge $700 or more until the deductible resets
• The Novo Nordisk commercial savings card can drop eligible copays to as low as $25, with monthly and annual caps; Medicare and Medicaid patients are excluded
• Compounded semaglutide via 503A pharmacies typically runs $199 to $399 per month, but it is not FDA-approved and not interchangeable with Ozempic
• The price you actually pay depends more on coverage status and pharmacy choice than on the drug itself

Direct answer

As of May 2026, brand Ozempic costs roughly $998 per month at cash retail in the United States. With commercial insurance covering it for type 2 diabetes, monthly copays usually fall between $25 and $80 after the manufacturer savings card. Without insurance, patients pay the full sticker price unless they qualify for the Novo Nordisk Patient Assistance Program or pivot to a compounded semaglutide alternative. Confirm current pricing directly with the pharmacy or manufacturer.

Table of contents

1. The actual sticker price right now
2. What you pay with commercial insurance
3. What you pay with Medicare or Medicaid
4. The Novo Nordisk savings card, in detail
5. Patient assistance: who actually qualifies
6. Pharmacy-to-pharmacy price variation
7. The compounded semaglutide alternative
8. International pricing and why it matters
9. The decision framework for cost-minimizing
10. The contrary view: why cheap isn't always the right answer
11. FAQ
12. Sources

The actual sticker price right now

Ozempic's wholesale acquisition cost (WAC) set by Novo Nordisk has held near $968.52 for a one-month pen since the most recent price action. Pharmacies layer their dispensing fee and cash markup on top, which is why the shelf price most patients see hovers around $998 in May 2026. Confirm current pricing directly with the pharmacy or manufacturer.

The "one-month pen" framing matters. A single Ozempic pen contains four weekly doses. There is no half-month or two-week prescription option from the manufacturer. The 0.25 mg starter pen, the 0.5 mg pen, the 1 mg pen, and the 2 mg pen all sit within a narrow wholesale band; they are not priced by dose.

Because Ozempic is FDA-approved for type 2 diabetes only, the price you encounter assumes a diabetes diagnosis. People seeking semaglutide for obesity will see different pricing through Wegovy (same active ingredient, different label), which Novo Nordisk prices higher.

What you pay with commercial insurance

Commercial coverage for Ozempic depends on three things: whether the plan's formulary includes it, the tier it sits on, and whether prior authorization is required.

For patients with a type 2 diabetes diagnosis on a plan that covers Ozempic at the preferred-brand tier, expect a monthly copay between $25 and $80. With the Novo Nordisk savings card layered on top, the out-of-pocket can drop further, sometimes to $25 flat.

High-deductible health plans behave differently. Until the deductible is met, the insurer applies the negotiated rate (often $700 to $900) to your responsibility. Patients on these plans often pay full price for the first one or two months of the calendar year, then see copays drop sharply once the deductible clears.

Plans that exclude Ozempic for weight-loss indications still cover it for diabetes. If the prescription is written for off-label weight loss, prior authorization typically denies and the patient owes cash.

What you pay with Medicare or Medicaid

Medicare Part D plans vary considerably. Ozempic for type 2 diabetes is widely covered, with copays generally between $40 and $100 in the initial coverage phase. Under the Inflation Reduction Act's Part D redesign that took effect in 2025, the annual out-of-pocket cap (now $2,000 in 2026) means a Medicare patient on Ozempic will hit the cap fairly quickly and pay zero for the rest of the year. The exact monthly cost before the cap depends on plan formulary placement.

Medicaid coverage varies by state. Most state Medicaid programs cover Ozempic for type 2 diabetes with prior authorization, typically requiring documented failure of metformin and one other agent. Copays under Medicaid are minimal where they apply.

Neither Medicare nor Medicaid covers Ozempic for weight loss as of May 2026. The Treat and Reduce Obesity Act, which would expand Medicare coverage of anti-obesity medications, has not passed.

The Novo Nordisk savings card, in detail

Novo Nordisk's commercial savings program for Ozempic has these mechanics as of May 2026:

Feature	Detail
Patient cost floor	As low as $25 per 1, 2, or 3-month fill
Monthly savings cap	Up to $150 per 1-month fill, $300 per 2-month, $450 per 3-month
Annual savings cap	Up to $1,800 per calendar year
Eligibility	Commercial insurance with a covered Ozempic prescription for type 2 diabetes; U.S. resident
Not eligible	Medicare, Medicaid, TRICARE, VA, or any other federal or state-funded program
How to enroll	NovoCare website or the printed card from your prescriber

The card stacks on top of insurance, not instead of it. If the plan denies the prior authorization or excludes Ozempic, the savings card does not turn into a coupon for the full price. It can only reduce the copay that insurance has already calculated.

Patient assistance: who actually qualifies

The Novo Nordisk Patient Assistance Program (PAP) provides Ozempic at no cost to qualifying patients. The criteria are stricter than the commercial savings card:

• U.S. resident
• Household income at or below 400% of the federal poverty level (this threshold updates each year)
• Uninsured, or insured without prescription drug coverage that includes Ozempic
• Prescribed for an on-label indication (type 2 diabetes)

Applications require provider attestation, financial documentation (tax return or pay stubs), and a current prescription. Approval is typically for 12 months and must be renewed. Verification can take three to six weeks. Patients who anticipate insurance changes (job transition, Medicare aging-in) should apply early.

Pharmacy-to-pharmacy price variation

The same NDC, same dose, same manufacturer can carry meaningfully different cash prices at pharmacies less than a mile apart. The drivers:

• Pharmacy type: independent pharmacies often have higher cash prices than chains because their acquisition costs are higher (less volume leverage). Costco's member pricing usually sits below national chains. Mail-order can be cheaper or more expensive depending on the payer.
• Regional pricing: cost of living, local payer mix, and competitive density change shelf pricing. Urban California pharmacies tend to price higher than rural Midwest pharmacies for the same drug.
• Discount cards: GoodRx, SingleCare, and similar programs negotiate their own pricing with PBMs and can pull a $1,050 retail down to roughly $950 in many markets. The discount card price replaces, not stacks with, insurance.
• Inventory and stocking decisions: pharmacies that stock Ozempic regularly often have better acquisition pricing than those that special-order it.

The practical advice: get three quotes before filling. Ask for the cash price with and without a discount card. If you have commercial insurance, ask what your copay will be before the pharmacy adjudicates the claim.

The compounded semaglutide alternative

Compounded semaglutide is a different product than brand Ozempic. It is mixed by a 503A state-licensed compounding pharmacy in response to an individual prescription. It is not FDA-approved. The FDA has at times restricted compounding of semaglutide based on whether semaglutide is on the shortage list, and the regulatory environment has shifted multiple times since 2023.

Compounded semaglutide is not interchangeable with Ozempic. Dosing units, vehicle, and bioavailability can differ. Patients considering a switch should discuss it with the prescriber.

Typical telehealth pricing as of May 2026 ranges from roughly $199 to $399 per month, often including the visit and shipping. Some platforms quote membership fees plus drug cost separately. The price advantage is real, but compounded products carry different risk and oversight than FDA-approved brands.

FormBlends operates a compounded semaglutide and tirzepatide program through partnered 503A pharmacies. Pricing on our platform is included in our published transparent rate sheet. Confirm current pricing directly with the pharmacy or manufacturer.

International pricing and why it matters

Ozempic's price in other developed countries sits well below the U.S. number. Approximate cash equivalent in May 2026:

Country	Approx. monthly cash price (USD equivalent)
United States	$998
Canada	$155
United Kingdom (private)	$190
Germany (insured)	$92
Australia (PBS)	$32 with PBS, ~$130 without
Japan	$110

These differences reflect price-negotiation systems, not different drug. The molecule and the pen are the same.

Importation for personal use exists in a regulatory gray zone. The FDA's Personal Importation Policy generally requires a prescription, a 90-day or less supply, and an indication that is not for serious unmet need; in practice, the agency has not aggressively enforced against patients importing personal-use quantities of GLP-1 drugs from licensed Canadian pharmacies, but seizures and delays do occur. Patients pursuing this route should weigh the savings against the risk of seizure, counterfeit product, and the lack of U.S. clinical oversight.

The decision framework for cost-minimizing

The path to the lowest legitimate price depends on your situation:

If you have commercial insurance and type 2 diabetes: confirm Ozempic is on formulary, get the prior authorization handled, and layer the Novo Nordisk savings card. Most patients in this scenario pay $25 to $80 monthly.

If you have commercial insurance and no diabetes diagnosis: Ozempic for weight loss is almost universally denied. Ask the prescriber about Wegovy (which has obesity on label) or about compounded semaglutide.

If you have Medicare: Ozempic for diabetes is widely covered. The Part D out-of-pocket cap means total annual exposure is bounded. Run the math on plan switching during open enrollment.

If you are uninsured with a diabetes diagnosis: apply for the Novo Nordisk Patient Assistance Program first. Approval means $0. While the application is pending, ask the prescriber for samples and price-shop pharmacies.

If you are uninsured without a diabetes diagnosis: brand Ozempic is unlikely to be affordable. Compounded semaglutide through a reputable telehealth platform with 503A pharmacy partners is the typical cost-minimizing path.

The contrary view: why cheap isn't always the right answer

The cost framing dominates this question, but the cheapest legitimate option isn't always the best clinical fit.

Brand Ozempic carries the regulatory backing of FDA approval. Manufacturing is centralized, controlled, and inspected. Adverse events are reported to FAERS. The dose-response is established. The supply chain is auditable.

Compounded semaglutide, by contrast, is a 503A product. The pharmacies vary in quality. There have been documented cases of mislabeling, incorrect concentrations, and contamination. The FDA's MedWatch system does receive compounded medication reports, but the surveillance is less robust than for FDA-approved products.

For a patient with stable type 2 diabetes who can access Ozempic at a manageable copay, switching to a $250 compounded alternative to save money may not be worth the regulatory uncertainty. For a patient with no insurance coverage and no realistic path to brand at any tolerable price, compounded semaglutide may be the only option that allows treatment at all.

The right cost decision is not the cheapest price. It is the best price given coverage, clinical fit, and tolerance for the regulatory profile of the option chosen.

FAQ

How much does Ozempic cost per month in 2026? As of May 2026, the cash retail price for a one-month supply of Ozempic averages around $998 in the United States, with pharmacy-to-pharmacy variation between roughly $920 and $1,080. Confirm current pricing directly with the pharmacy or manufacturer.

Why does the price of Ozempic vary between pharmacies? Pharmacies negotiate their own acquisition costs and apply different cash markups. Regional cost-of-living, payer mix, and inventory turnover all affect shelf price. The same NDC can swing $150 between two pharmacies a few miles apart.

What does Ozempic cost with insurance? When a plan covers Ozempic for type 2 diabetes, copays usually fall between $25 and $80 per month for preferred-brand tiers. High-deductible plans may charge the full negotiated price until the deductible is met.

Is there a manufacturer coupon for Ozempic? Novo Nordisk offers a commercial savings card that can lower copays to as little as $25 per fill, subject to monthly and annual caps. Medicare, Medicaid, and uninsured patients are not eligible.

Does NovoCare or patient assistance help with Ozempic cost? The Novo Nordisk Patient Assistance Program can provide Ozempic at no cost to qualifying uninsured U.S. residents under defined income limits. Application is provider-supported.

Is compounded semaglutide cheaper than Ozempic? Compounded semaglutide from a 503A pharmacy commonly runs $199 to $399 per month as of May 2026. It is not FDA-approved and not interchangeable with Ozempic.

Why is Ozempic so expensive in the United States? Patent protection, the absence of centralized national price negotiation, PBM rebate structures that often bypass patients, and pricing-to-market for a high-demand category.

Does Costco or another big-box pharmacy sell Ozempic cheaper? Costco's cash price for Ozempic tends to sit below the national average for members. GoodRx, SingleCare, and similar cards can match it at chain pharmacies.

Will my Ozempic price change if I move up in dose? No. Novo Nordisk prices the 0.25, 0.5, 1, and 2 mg pens at roughly the same wholesale level. Cash prices at the pharmacy are within a few dollars across doses.

Can I get Ozempic for free if I can't afford it? Possibly. The Novo Nordisk Patient Assistance Program provides Ozempic at no cost to qualifying patients. Eligibility includes income limits and uninsured status.

Does insurance ever cover Ozempic for weight loss? Rarely. Most plans only cover Ozempic for the FDA-approved type 2 diabetes indication. Weight-loss coverage typically goes through Wegovy if covered at all.

Sources

1. Novo Nordisk. Ozempic Wholesale Acquisition Cost and Savings Program documentation. NovoCare.com. 2026.
2. Centers for Medicare and Medicaid Services. Medicare Part D 2026 redesign and out-of-pocket cap. CMS.gov. 2026.
3. U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. FDA.gov. 2024.
4. Kaiser Family Foundation. Prescription Drug Coverage in Commercial and Medicare Plans, 2025-2026.
5. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
6. American Diabetes Association. Standards of Medical Care in Diabetes. 2026.
7. RAND Corporation. International Prescription Drug Price Comparisons. 2024.
8. Inflation Reduction Act of 2022. Medicare Drug Price Negotiation Provisions.
9. FDA. Personal Importation Policy. Regulatory Procedures Manual.
10. USP. Standards for Compounded Sterile Preparations (USP 797). 2023.
11. Government Accountability Office. Prescription Drug Pricing Report. 2025.
12. NovoCare Patient Assistance Program. Application guidelines and income thresholds. 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform connecting patients with independent licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. Treatment decisions are made by independent licensed clinicians based on individual evaluation.

Compounded Medication Notice. Compounded semaglutide referenced in this article is prepared by 503A state-licensed compounding pharmacies in response to individual prescriptions. Compounded preparations are not FDA-approved and have not undergone the same review as FDA-approved drugs. They are not interchangeable with brand Ozempic.

Results Disclaimer. Pricing figures cited reflect publicly available retail, wholesale, and program data as of May 2026 and change frequently. Individual out-of-pocket cost depends on insurance, location, pharmacy, and program eligibility. Verify pricing directly with the pharmacy or manufacturer before relying on any figure here.

Trademark Notice. Ozempic, Wegovy, NovoCare, and the Novo Nordisk logo are registered trademarks of Novo Nordisk A/S. Costco is a registered trademark of Costco Wholesale Corporation. GoodRx and SingleCare are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.